AbbVie

Open: 174.46 Close: 173.29 Change: -1.17

You're running out of time to find out about AbbVie using an AI.

Are looking for the most relevant information about AbbVie? Investor spend a lot of time searching for information to make investment decisions in AbbVie. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, first, stock, close, Abbvie, company, Nvidia, and the most common words in the summary are: abbvie, stock, market, best, job, immunogen, abbv, . One of the sentences in the summary was: The pharmaceutical giant had expected to take a hit to Botox.. Other searches related …

Concept Map

Semantic Network

Stock Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenos.

Today's Summary

AbbVie (ABBV) stock is down -0.12% while the S&P 500 has fallen -1.15% as of 11:57 AM on Tuesday, Feb 13. The pharmaceutical giant had expected to take a hit to Botox.

Today's News

Nvidia closes with a market cap above Amazons for first time since 2002 Stock-market tumble shows investors now face ‘Feds reality in inflation fight. Nvidia closes. with a price cap above. Amazon for first. time since. 2002. AbbVie is lowering its current quarter guidance because of its acquisition of ImmunoGen. The drug maker expects both Skyrizi and Rinvoq to continue growing their sales at a good clip well into the 2030s. AbbVie shares were 0.3% lower at $173.52 per share in intraday trading as of about noon ET Monday. ELAHERE (mirvetuximab soravtansine-gynx) is the first and only antibody-drug conjugate (ADC) approved by the U.S. AbbVie (ABBV) stock is down -0.12% while the S&P 500 has fallen -1.15% as of 11:57 AM on Tuesday, Feb 13. The pharmaceutical giant had expected to take a hit to Botox sales in 2023. Leerink Partners report indicates AbbVies in-line performance for the fourth quarter of 2023 and an increase in long-term guidance for Skyrizi and Rinvoq. Upcoming key events, such as FTC actions, product approvals, and clinical trial readouts, could significantly influence Abbvies future performance and success. AbbVie is in the Health Care sector and Biotechnology industry. There is no upcoming split for Abbvie. AbbVie revises Q1 2024 adjusted EPS Guidance from $2.30-$2.34 to $2.26-30 versus Consensus of $ 2.35. Cerevel Therapeutics stock is climbing higher. Abbvie stock quotes can also be displayed as NYSE : ABBV. If you had invested in AbbVie stock at $35.12 in 2013, your return over the last 11 years would have been 392.8%. AbbVie and Anima Biotech pair up on discovery and development of mRNA Biology Modulators. The companies announced an up to $582 million collaboration announced by the companies. AbbVie Inc. is a global biopharmaceutical company focused on creating medicines and creating medicines that put the worlds first impact on patients and communities. AbbVie celebrates #WorldCancerDay ahead of World Cancer Day. Abbvie closes $10.1b buyout of immunogen.com on Monday.

Stock Profile

"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; and Genentech, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois."

Keywords

How much time have you spent trying to decide whether investing in AbbVie? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, first, stock, close, Abbvie, company, Nvidia, and the most common words in the summary are: abbvie, stock, market, best, job, immunogen, abbv, . One of the sentences in the summary was: The pharmaceutical giant had expected to take a hit to Botox.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #abbvie #stock #market #best #job #immunogen #abbv.